The new NIH Transformative R01 (T-R01) program, announced in September 2008, will specifically fund high-risk research in areas that are in need of radical change and progress such as pharmacogenomics, understanding and facilitating behavioral changes for disease intervention, mitochondrial variation, and dysfunction and chronic pain management. The applications for the 5-year grants are due by 29 January 2009. The grant proposals, which are unique from traditional R01 grading systems, will be evaluated by a distinctive review process being piloted by the NIH Center for Scientific Review (CSR). This new research support and review program aims to stimulate scientific creativity and unique approaches, which will hopefully lead to high-impact discoveries and breakthroughs. Further information on this program can be found online at: http://nihroadmap.nih.gov/T-R01
DMM Journal Meeting 2023: Infectious Diseases Through an Evolutionary Lens
The abstract submission deadline for our 2023 Journal Meeting ‘Infectious Diseases Through an Evolutionary Lens’ is 14 July 2023. Find out more and register for the 2023 Journal Meeting here.
The Forest of Biologists
The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Propose a new Workshop for 2025
We are now accepting proposals for our 2025 Biologists Workshops programme. As the scientific organiser, your involvement will be focused on the science. We'll take care of all the logistics. In 2025 we'll continue our efforts to diversify our Workshop programme and will be reserving one of our Workshops for an application from a Global South (GS) country to host an event overseas.
At a Glance - in vitro cardiac models
In our recent At a Glance feature Lika Drakhlis and Robert Zweigerdt provide an overview of in vitro cardiac models, their advantages and limitations and their applications for disease modelling and therapeutic development.
Perspective - Designer pigs for xenogeneic heart transplantation and beyond
Xenotransplantation of porcine hearts is a potential option for patients who cannot receive human organs. Eckhard Wolf and colleagues elaborate on how genetically engineered pigs can provide a powerful platform for restoration of cardiac function.
Social media
